Ahmedabad, January 15, 2026: Zydus Lifesciences Limited (NSE: Zyduslife, BSE: 532321) on Thursday announced the successful completion of its multi-pronged acquisition involving equity participation in U.S.-based Agenus Inc. and the takeover of two advanced biologics manufacturing facilities in California, marking a significant expansion of its global biologics footprint.The transaction includes the acquisition of biologics manufacturing facilities located in Emeryville and Berkeley, California, along with a strategic equity investment in Agenus Inc. Through its wholly owned subsidiary, Zynext Ventures USA LLC, Zydus has acquired 2,133,333 equity shares of Agenus Inc., representing a 5.9 percent stake on a fully diluted basis.Entry...